NumFin

JCR Pharmaceuticals Co., Ltd.

符号: JCRRF

PNK

6.2

USD

今天的市场价格

  • 18.8882

    市盈率

  • -0.0016

    PEG比率

  • 773.77M

    MRK市值

  • 0.00%

    DIV收益率

JCR Pharmaceuticals Co., Ltd. (JCRRF) 财务报表

Download
年度季度
线性对数
在图表中，您可以看到 的动态默认数字 JCR Pharmaceuticals Co., Ltd. (JCRRF). 的默认数据。公司收入显示 NaN M 的平均值，即 NaN % 增长率。整个期间的平均毛利润为 NaN M，即 NaN %. 平均毛利率为 NaN %. 公司去年的净收入增长率为 NaN %，等于 NaN % % 整个公司历史的平均增长率.,

年度季度
10Y20Y30Y40Y

资产负债表

深入分析 JCR Pharmaceuticals Co., Ltd. 的财务轨迹，我们可以看到其平均资产增长率。有趣的是，这一增长率为 ，反映了公司的高点和低点。与季度相比，这一数字调整为. 回顾过去一年，总资产变化为 NaN. 股东权益总额所体现的股东价值是以报告货币计算的 NaN. 这方面的年同比变化率为 NaN%.

common:word.in-mln

USD
Growth
TTM2023202220212020201920182017201620152014201320122011201020092008200720062005

balance-sheet.row.cash-and-short-term-investments

0132783097726260
11193
8497
6112
5809.8
3875.6
4873.5
7244.3
4691.9
4067
4419
6235.9
5952.6
6985.4
4096
3126.8
3346.5

balance-sheet.row.short-term-investments

0-214244-225
220
661
1217
300.3
1927
3736
6196.8
3869.5
3201
2979.7
4333.9
3919.9
5925.5
3183.2
2468.2
2619

balance-sheet.row.net-receivables

011137155858183
7977
8835
7599
5824.9
5994.4
5621.1
4565.7
5449.1
4580.2
4407.6
3378.3
3000.5
2906.7
3033
4012.6
4139.8

balance-sheet.row.inventory

0185141463613554
8855
9117
9023
7737.7
7342.9
6401.5
5105.4
4990.2
5110.4
4574.8
4097.4
3214.5
3339.5
3667.1
3953.6
4606.2

balance-sheet.row.other-current-assets

04873990548
317
919
593
942.7
1153.4
294.9
457.4
854.6
485.3
419.3
1239.4
2067.3
1373.3
2452
556.8
506.8

balance-sheet.row.total-current-assets

0478026218848545
28342
27368
23327
20315.2
18366.2
17191
17372.8
15985.8
14242.8
13820.7
14951
14234.9
14605
13248.2
11649.8
12599.3

balance-sheet.row.property-plant-equipment-net

0326812678217172
14875
11061
10853
11387.7
11445
11611.9
11392.1
10367.1
9737.2
10319.2
8911.7
7435
6722
6665.2
6829.2
7135

balance-sheet.row.goodwill

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.intangible-assets

0365229603232
263
0
0
0
0
0
0
0
99.1
120.5
118.9
59.3
18.7
20
16.9
21.9

balance-sheet.row.goodwill-and-intangible-assets

0365229603232
263
110
112
67.6
84
75.2
94.6
78.8
99.1
120.5
118.9
59.3
18.7
20
16.9
21.9

balance-sheet.row.long-term-investments

0908119862797
2188
2280
1977
3287.2
2320.7
155.1
-2900.5
-335.9
49
1432.3
188.9
-1416.5
-4203.8
-17.8
-859.7
-1567.2

balance-sheet.row.tax-assets

0135724331739
721
378
1485
576.6
2207.9
4093.7
6365.6
3869.5
3201
2979.7
4333.9
3919.9
5925.5
3183.2
24.5
274.2

balance-sheet.row.other-non-current-assets

0362783296
1383
1317
643
1327.3
3130.9
5052.7
7505.3
5191.2
4839.2
4124.7
4977.8
4454.4
7076.8
4487.1
3138.2
3336

balance-sheet.row.total-non-current-assets

0471333494425236
19430
15146
15070
16069.9
16980.6
16895
16091.5
15301.2
14724.5
15996.8
14197.2
10532.3
9613.8
11154.6
9149.1
9199.9

balance-sheet.row.other-assets

0223
3
2
1
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-assets

0949379713473784
47775
42516
38398
36385
35346.8
34086.1
33464.3
31287
28967.3
29817.5
29148.2
24767.2
24218.8
24402.8
20798.9
21799.2

balance-sheet.row.account-payables

0156313242932
679
586
585
700.3
783.4
534
697.1
735.6
229.4
955.2
914.9
808.9
438.3
345.4
331.9
382.6

balance-sheet.row.short-term-debt

0173001515012850
4926
3808
3086
1723.8
1985.4
2158.2
2101.4
2278.1
2238.7
2025.5
1994.5
1893.2
1877.2
2282.9
2404
2909.6

balance-sheet.row.tax-payables

03359152646
534
801
887
69.6
764.2
76.9
501.7
308.8
138.4
323.9
553.2
0
0
0
48.4
28.4

balance-sheet.row.long-term-debt-total

0550029505250
3831
1923
2718
3115.1
1208.3
1479.8
2158.1
1874.4
1801.2
2067
3163.1
3190.4
3199.2
2900.5
1844.1
3537.9

Deferred Revenue Non Current

0-428-343-378
-343
-440
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.deferred-tax-liabilities-non-current

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

balance-sheet.row.other-current-liab

012975134729687
651
2746
1907
2282.9
3298.3
2442.8
2865.5
2612.2
1952.8
1852.2
2452.8
1791.5
1747.7
1415
655.2
672.2

balance-sheet.row.total-non-current-liabilities

0676339946203
4763
2961
3766
4092.2
2217
2686.2
3219.6
2164.4
1913.3
2152.4
3302.3
3288.8
3303.4
3108.9
1931.8
3602.9

balance-sheet.row.other-liabilities

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.capital-lease-obligations

0734442
77
251
411
632.1
786.6
971.5
1127.7
1280.1
1534.6
1713.2
739.9
704.4
0
0
0
0

balance-sheet.row.total-liab

0425254604835231
15197
11645
10871
8799.2
8284.1
7821.2
8883.5
7790.4
6334.2
6985.4
8664.4
7782.5
7366.7
7152.2
5322.9
7567.3

balance-sheet.row.preferred-stock

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.common-stock

0906190619061
9061
9061
9061
9061.9
9061.9
9061.9
9061.9
9061.9
9061.9
9061.9
8061.9
7504.9
7504.9
7504.9
5554.9
5171.2

balance-sheet.row.retained-earnings

0342733324120904
15039
13350
10469
8149.3
6930.1
5780.5
4445.3
3562
3211.9
2964.6
2523.8
1474.1
1204.4
1077.1
3105
3390

balance-sheet.row.accumulated-other-comprehensive-income-loss

0142111841159
1262
1286
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.other-total-stockholders-equity

0740673957255
7027
6985
7812
10373.9
11070
11421.9
11073.1
10872.2
10359
10805.4
9897.9
8001
8131
8659.4
6804.8
5665.9

balance-sheet.row.total-stockholders-equity

0521615088138379
32389
30682
27342
27585
27062
26264.3
24580.2
23496.1
22632.8
22831.8
20483.5
16979.9
16840.3
17241.4
15464.7
14227.1

balance-sheet.row.total-liabilities-and-stockholders-equity

0949379713473784
47775
42516
38398
36385
35346.8
34086.1
33464.3
31287
28967.3
29817.5
29148.2
24767.2
24218.8
24402.8
20798.9
21799.2

balance-sheet.row.minority-interest

0251205174
189
189
185
0.9
0.8
0.6
0.6
0.5
0.3
0.3
0.2
4.8
11.8
9.2
11.3
4.8

balance-sheet.row.total-equity

0524125108638553
32578
30871
27527
-
-
-
-
-
-
-
-
-
-
-
-
-

balance-sheet.row.total-liabilities-and-total-equity

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

Total Investments

0886722302572
2408
2941
3194
3587.6
4247.6
3891.1
3296.3
3533.6
3250
4412
4522.8
2503.4
1721.8
3165.4
1608.5
1051.8

balance-sheet.row.total-debt

0228001810018100
8757
5731
5804
4838.9
3193.7
3638
4259.5
4152.5
4039.8
4092.4
5157.5
5083.6
5076.4
5183.4
4248.1
6447.5

balance-sheet.row.net-debt

09522-12633-8160
-2216
-2105
909
-670.6
1245.1
2500.5
3212
3330.1
3173.9
2653.2
3255.5
3050.8
4016.5
4270.6
3589.5
5720

现金流量表

在 JCR Pharmaceuticals Co., Ltd. 的财务状况中，自由现金流在过去一段时间内发生了显著变化，呈现出 NaN 的转变。该公司最近通过发行 NaN 扩大了股本，与上一年相比出现了NaN 的差异. 公司的投资活动产生了现金使用净额，按报告货币计算达到NaN. 与上一年相比， NaN 发生了变化. 在同一时期，公司记录了 NaN, NaN 和 NaN，这对于了解公司的投资和还款策略具有重要意义. 公司的融资活动导致使用的现金净额为NaN，同比差异为NaN. 此外，公司还将NaN 用于向股东分红。与此同时，该公司还采取了其他财务措施，即 NaN，这也对其在此期间的现金流产生了重大影响. 这些组成部分合在一起，全面反映了公司的财务状况和现金流管理的战略方针。

common:word.in-mln

USD
Growth
TTM2023202220212020201920182017201620152014201320122011201020092008200720062005

cash-flows.row.net-income

05412194048653
3422
4928
3895
2492.8
2459.3
2334.3
1677.5
1064.8
942.1
1274.1
1583.9
562.1
436.9
-611.8
39.2
-1927.8

cash-flows.row.depreciation-and-amortization

0199719451892
1434
1343
1382
1447.5
1407.7
1352.4
1112
979.2
1101.4
975.7
743.3
694.8
575.9
586
620.5
548.3

cash-flows.row.deferred-income-tax

0-9221-3074-983
-1291
-1310
-145
-1257
-392.8
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.stock-based-compensation

0173177149
175
144
77
79.4
85.6
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.change-in-working-capital

0-2956-9030323
1398
-1585
-2391
-208.2
-1631.4
-2178.5
2298.8
-342.7
-2427.9
-1588.8
-619.2
254
627
814.1
759.9
1412.7

cash-flows.row.account-receivables

03269-7501-204
892
-1639
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.inventory

0-3877-1082-4699
258
-157
-1314
-402.9
-947
-1292.5
-138.8
95.7
-583.9
-574.4
-953.6
112.5
320.1
294.3
650.5
2186.4

cash-flows.row.account-payables

0238-16082253
92
1639
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.other-working-capital

0-258611612973
156
-1428
-1077
194.7
-684.3
-886
2437.6
-438.4
-1843.9
-1014.3
334.3
141.5
306.9
519.8
109.4
-773.6

cash-flows.row.other-non-cash-items

0-905-133307
-211
385
315
-1160.1
-119.4
-1009.1
-522.9
-39.9
-36.7
-679.3
649.5
314.7
283.7
341.1
-673
608.1

cash-flows.row.net-cash-provided-by-operating-activities

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.investments-in-property-plant-an-equipment

0-8560-11333-7527
-4838
-895
-999
-1550.6
-1413.9
-1340.3
-2409.6
-1048
-292.1
-1152.2
-1922.6
-847.1
-2091.6
-2152.4
-166.3
-976

cash-flows.row.acquisitions-net

0-67178167-2747
0
0
-11
0
0
-62.7
64.6
0
0
9.6
-6.9
-8.9
901
-1177.2
0
0

cash-flows.row.purchases-of-investments

0-906-300-391
-30
-100
-1105
-42.8
-724.4
-2040.6
-1071.9
-308.3
-528.5
-1326.2
-3231.3
-2095.4
-1749.8
-4415.7
-52.4
-143.4

cash-flows.row.sales-maturities-of-investments

0259300584
798
1257
450
736.3
1182.9
1957.6
750.2
1150.5
1906.8
421.9
1429.6
2700
1100
1177.7
397.5
0

cash-flows.row.other-investing-activites

0922-846791
-91
-22
78
15.6
-25.2
-59.1
63
27.3
453.4
-155.2
334.4
49.3
823.8
-1221.3
-45.7
-114.3

cash-flows.row.net-cash-used-for-investing-activites

0-15002-3250-3290
-4161
240
-1587
-841.4
-980.6
-1419.7
-2668.3
-178.5
1539.7
-2211.8
-3396.7
121.8
-571.5
-4634.5
133.1
-1233.7

cash-flows.row.debt-repayment

0-3050-750-650
-850
-413
-233
-550.3
-759.5
-665.3
-580.6
-430.8
-468
-666.4
-731.6
-367.2
-985.8
-485.4
-817.2
-1899.7

cash-flows.row.common-stock-issued

0101013
15
26
0
0
0
0
0
0
0
0
2256.5
0
0
3875.6
0
0

cash-flows.row.common-stock-repurchased

0-10-10-13
-15
-26
0
0
0
0
0
0
0
0
537.7
0
0
1409.6
0
0

cash-flows.row.dividends-paid

0-2739-2169-1083
-989
-834
-748
-699.3
-640
-592.4
-412.5
-382.2
-385.8
-485.6
-253.2
-270.2
-273.3
-268.1
-242.1
-234

cash-flows.row.other-financing-activites

0773774010037
3887
330
-1194
1395.9
85.5
-3.7
623.7
574.9
-211.5
-124.5
484.7
-638.8
746.9
1409
-48.5
3814.4

cash-flows.row.net-cash-used-provided-by-financing-activities

01948-21798304
2048
-917
-2175
146.3
-1314
-1261.4
-369.4
-238.1
-1065.3
-1276.5
1756.4
-1276.2
-512.2
4531.2
-1107.8
1680.6

cash-flows.row.effect-of-forex-changes-on-cash

01099612-22
20
12
14
-15
-27.1
44.3
104.4
39
-0.3
-15.6
-3.3
-35.4
-16.3
10.9
16
4.8

cash-flows.row.net-change-in-cash

0-17455447315332
2837
3241
-614
1941.2
-120
-2137.7
1632.1
1283.8
53
-3522.3
713.9
635.7
823.5
1037
-212.1
1093

cash-flows.row.cash-at-end-of-period

0132783073326260
10928
8091
4850
5464.5
3523.3
3643.3
5781
4148.9
2865.1
2812.1
6334.4
5620.5
4984.8
4161.3
3124.3
3336.4

cash-flows.row.cash-at-beginning-of-period

0307332626010928
8091
4850
5464
3523.3
3643.3
5781
4148.9
2865.1
2812.1
6334.4
5620.5
4984.8
4161.3
3124.3
3336.4
2243.4

cash-flows.row.operating-cash-flow

0-5500928910341
4927
3905
3133
2651.3
2201.7
499.1
4565.4
1661.4
-421.1
-18.3
2357.5
1825.6
1923.5
1129.5
746.6
641.3

cash-flows.row.capital-expenditure

0-8560-11333-7527
-4838
-895
-999
-1550.6
-1413.9
-1340.3
-2409.6
-1048
-292.1
-1152.2
-1922.6
-847.1
-2091.6
-2152.4
-166.3
-976

cash-flows.row.free-cash-flow

0-14060-20442814
89
3010
2134
1100.7
787.8
-841.2
2155.8
613.4
-713.2
-1170.6
434.9
978.4
-168
-1022.9
580.3
-334.6

利润表行

JCR Pharmaceuticals Co., Ltd. 的收入与上期相比变化了 NaN%。据报告, JCRRF 的毛利润为 NaN。该公司的营业费用为 NaN，与上年相比变化了 NaN%. 折旧和摊销费用为 NaN，与上一会计期间相比变化了 NaN%. 营业费用报告为 NaN，显示NaN% 的同比变化。 销售和营销费用为 NaN, 其中 NaN% 与上年相比发生了变化。 基于近期数据的EBITDA为 NaN，同比增长NaN%. 营业收入为 NaN，与上年相比变化了NaN%. 净利润的变化率为 NaN%。去年的净收入为NaN.

common:word.in-mln

USD
Growth
TTM2023202220212020201920182017201620152014201320122011201020092008200720062005

income-statement-row.row.total-revenue

0343435108230085
24781
23160
20594
18085
17438.4
16855.7
15705.9
14099.9
12845.1
14457.8
14387.4
12082.7
11871.9
8544.7
7648.8
8099.7

income-statement-row.row.cost-of-revenue

08886104617812
7901
6567
6128
5731.7
6459.4
5740.9
5842.1
5036.9
4213
5227.3
4142.5
3555.7
3824.7
2818.3
2881.4
3653.6

income-statement-row.row.gross-profit

0254574062122273
16880
16593
14466
12353.3
10979
11114.7
9863.8
9063
8632
9230.5
10244.9
8527
8047.2
5726.4
4767.4
4446.1

income-statement-row.row.gross-profit-ratio

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.research-development

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-general-administrative

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-expenses

0583861
4
16
10
51.7
107
109.7
26.2
22.7
24.8
16.1
128.1
121.7
248.7
-287.9
-199.1
-2331.4

income-statement-row.row.operating-expenses

0204802068614003
13635
11625
10681
9991.3
8826.2
9100.1
8318.4
7912.1
7542.3
7822.9
8237.3
7980.5
7765.2
5890
4802.8
3986.6

income-statement-row.row.cost-and-expenses

0293663114721815
21536
18192
16809
15723
15285.6
14841.1
14160.4
12949
11755.3
13050.3
12379.8
11536.2
11589.9
8708.3
7684.2
7640.2

income-statement-row.row.interest-income

03377
19
20
20
16.6
27.1
31.1
34.4
36.4
50.2
56.7
47.1
58.4
52.6
45.8
4
3.8

income-statement-row.row.interest-expense

0444542
22
21
27
29
32.7
38.1
43.5
50.3
57.5
59
69
63
65.2
58.7
51.6
49.6

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.total-other-income-expensenet

0437-529384
178
-39
111
130.8
306.5
319.7
132
-86.1
-120.9
-97.3
-346.3
-142.5
-146.3
-184.4
284
-62.9

income-statement-row.row.ebitda-ratio-caps

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-operating-expenses

0583861
4
16
10
51.7
107
109.7
26.2
22.7
24.8
16.1
128.1
121.7
248.7
-287.9
-199.1
-2331.4

income-statement-row.row.total-operating-expenses

0437-529384
178
-39
111
130.8
306.5
319.7
132
-86.1
-120.9
-97.3
-346.3
-142.5
-146.3
-184.4
284
-62.9

income-statement-row.row.interest-expense

0444542
22
21
27
29
32.7
38.1
43.5
50.3
57.5
59
69
63
65.2
58.7
51.6
49.6

income-statement-row.row.depreciation-and-amortization

0199719451892
1434
1343
1382
1447.5
1407.7
1352.4
1112
979.2
1101.4
975.7
743.3
694.8
575.9
586
620.5
548.3

income-statement-row.row.ebitda-caps

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.operating-income

04975199338269
3244
4967
3784
2362
2152.8
2014.6
1545.5
1150.9
1063
1371.4
1930.3
704.6
583.2
-427.4
-244.8
-1864.8

income-statement-row.row.income-before-tax

05412194048653
3422
4928
3895
2492.8
2459.3
2334.3
1677.5
1064.8
942.1
1274.1
1583.9
562.1
436.9
-611.8
39.2
-1927.8

income-statement-row.row.income-tax-expense

0162548861764
742
1217
825
629.5
669.7
651.9
381.1
334
308
347.5
279.8
21.2
34.4
1139.6
69
-659

income-statement-row.row.net-income

03772145076892
2678
3715
3070
1863.2
1789.5
1682.4
1296.2
730.7
634
926.5
1302.9
539.9
400
-1751.1
-31.9
-1272.4
类似股票
您可能还对以下内容感兴趣：
300357.SZ
Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd..
25.97 CNY
SHZ
OTSKF
Otsuka Holdings Co., Ltd..
38.358 USD
PNK
MRK.PA
Merck & Co., Inc..
101.4 EUR
EURONEXT
AMG.DE
Amgen Inc..
259.8 EUR
XETRA
000908.SZ
Hunan Jingfeng Pharmaceutical Co.,Ltd..
2.07 CNY
SHZ
BRM.DE
Bristol-Myers Squibb Company.
49.65 EUR
XETRA
GSK.L
GSK plc.
1661.8 GBp
LSE
LYPHF
Luye Pharma Group Ltd..
0.38625 USD
PNK
MYX.AX
Mayne Pharma Group Limited.
6.8 AUD
ASX
HZNP
Horizon Therapeutics Public Limited Company.
116.3 USD
NASDAQ

常见问题

什么是 JCR Pharmaceuticals Co., Ltd. (JCRRF) 总资产是多少？

JCR Pharmaceuticals Co., Ltd. (JCRRF) 总资产为 94937000000.000.

什么是企业年收入？

年收入为 N/A.

企业利润率是多少？

公司利润率为 0.748.

什么是公司自由现金流？

自由现金流为 45.128.

什么是企业净利润率？

净利润率为 0.130.

企业总收入是多少？

总收入为 0.189.

什么是 JCR Pharmaceuticals Co., Ltd. (JCRRF) 净利润？{{符号}}净利润（净收入）是多少？

净利润（净收入）为 3772000000.000.

公司总债务是多少？

债务总额为 22800000000.000.

营业费用是多少？

运营支出为 20480000000.000.

公司现金是多少？

企业现金为 0.000.